title: [Surgical treatment of type 2 diabetes mellitus].
abstract: Sustained remission of type 2 diabetes mellitus and significantly improved hyperlipidemia and arterial hypertension, control has been achieves in both lean and obese patient after bariatric surgery procedures or other gastrointestinal surgical procedures. It has been demonstrated that the metabolic effects of bariatric surgery in these patients derives not only in reducing weight and caloric intake, but also endocrine changes resulting from surgical manifestation gastrointestinal tract. In this article we review the clinical outcomes of such interventions (collectively called "metabolic surgery") and the perspectives on the role that these surgeries play in the treatment of patients with type 2 diabetes mellitus.
authors.affiliation: Unidad de Terapia Intensiva, Fundación Clínica Médica Sur, México DF, Mexico. sgmena@yahoo.com.
authors.forename: Raúl
authors.initials: R
authors.lastname: Carrillo-Esper
authors.affiliation: >Unidad de Terapia Intensiva, Fundación Clínica Médica Sur, México DF, Mexico.
authors.forename: María Jimena
authors.initials: MJ
authors.lastname: Muciño-Bermejo
mesh_terms: D050110:Bariatric Surgery; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000378:metabolism / Q000601:surgery*; D002149:Energy Intake; D005743:Gastrectomy; D054439:Ghrelin / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D054795:Incretins / Q000378:metabolism; D007333:Insulin Resistance; D007421:Intestine, Small / Q000378:metabolism / Q000503:physiopathology; D019894:Peptide YY / Q000378:metabolism; D011178:Postgastrectomy Syndromes / Q000503:physiopathology; D015431:Weight Loss
chemical_list: D054439:Ghrelin; D054795:Incretins; D019894:Peptide YY
keywords: Bariatric surgery; cirugía bariátrica; cirugía metabólica; diabetes mellitus tipo 2; metabolic surgery